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Diacylglycerol kinases (DGKs) are a family of enzymes that catalyze the ATP-dependent
phosphorylation of diacylglycerol (DAG) to phosphatidic acid (PtdOH). The recognition of
the importance of these enzymes has been increasing ever since it was determined that
they played a role in the phosphatidylinositol (PtdIns) cycle and a number of excellent
reviews have already been written [(see van Blitterswijk and Houssa, 2000; Kanoh et al.,
2002; Mérida et al., 2008; Tu-Sekine and Raben, 2009, 2011; Shulga et al., 2011;
Tu-Sekine et al., 2013) among others]. We now know there are tenmammalian DGKs that
are organized into five classes. DGK-θ is the lone member of the Type V class of DGKs
and remains as one of the least studied. This review focuses on our current understanding
of the structure, enzymology, regulation, and physiological roles of this DGK and suggests
some future areas of research to understand this DGK isoform.
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STRUCTURE
Arguably, our lack of knowledge about the three dimensional structure of mammalian DGKs
remains as one of our most difficult challenges. Currently, our knowledge of the structural features
of DGKs is essentially limited to the primary sequence of these enzymes (Figure 1). As noted in
many excellent reviews (for example, see van Blitterswijk and Houssa, 2000; Kanoh et al., 2002;
Mérida et al., 2008; Shulga et al., 2011) DGK-θ’s major distinguishing feature in this regard is
that it possess three, instead of two, C1 domains. Like other DGKs, the C1 domains of DGK-θ
is homologous to PKC C1A and C1C domains with an extended region closest to the presumed
catalytic domain near the C terminus. Despite the temptation to assume these domains bind
DAG, their precise role remains unclear. Such caution is supported by the observation that the
C1 domains of DGK-θ does not bind phorbol esters (Shindo et al., 2003). Further, the structural
studies of Hurley and colleagues showed clear differences between these domains and those found
in PKCs (Hurley et al., 1997). As suggested previously (Shulga et al., 2011), these data suggest that
these DGK-θ domains may bind other lipids or participate in protein-protein interactions. Such a
notion is supported by the evidence showing the C1 domain of another DGK, DGKζ, mediates the
interactions with β-arrestins (Nelson et al., 2007) and Rac1 (Yakubchyk et al., 2005). We should
note, that there is some evidence that this domain may be involved in membrane association in
response to activation of some G-protein coupled receptors (van Baal et al., 2005).
Another feature of DGK-θ is the presence of a sequence with homology to Ras binding domains
which is termed the Ras-Association (RA) domain (Houssa et al., 1997). It is important to note,
however, that an in silico analyses based on binding energies predicts that the RA domain of DGK-θ
probably does not bind Ras (Kiel et al., 2005). It is interesting, in this regard, that DGK-θ has been
shown to bind a different small GTPase, active (GTP-bound) RhoA, and this association inhibits
the kinase activity (Houssa et al., 1997). As with the C1 domains, however, it is not clear that RhoA
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FIGURE 1 | Linear domain structure of DGK-θ.
binds specifically to this domain either and it is equally unclear
as to whether RhoA is a regulator under various physiological
conditions (see Regulation below).
Another major distinguishing feature of DGK-θ is the
presence of a proline/glycine-rich region near its N-terminus. It
is interesting to speculate that this region, may bind to proteins
containing an SH3 domain given the presence of a pXPXXPmotif
(Yu et al., 1994). Further, a splice form of DGKδ, DGKδ2, also
contains a proline-rich domain which is believed to play a role
in regulating its membrane association in response to certain
stimuli (Takeuchi et al., 2012). While these data are interesting,
the precise role for the proline/glycine-rich domain in DGK-θ has
not been fully examined.
The above clearly highlights the need for a greater
understanding of the structural features of DGK-θ as well as other
DGKs. Much of our structural understanding of these enzymes
comes from studies of two prokaryotic DGKs. The first is a
DGK found in the gram-negative organism Escherichia coli. This
enzyme is different from the mammalian enzymes in that in
contains three membrane spanning domains and functions as a
trimer (see Van Horn and Sanders, 2012). Another DGK, found
in gram-positive organisms such as Staphylococcus aureus, is a
soluble enzyme with 15–18% homology to human DGKs (Miller
et al., 2008). The structural studies of this enzyme showed the
active site appears to form at a homodimer interface. Further,
the data suggest a putative DAG substrate recognition loop that
may provide an important difference between DGKs and related
enzymes such as YegS and NAD kinases that are not bona fide
DGKs (Bakali et al., 2007; Nichols et al., 2007; see Miller et al.,
2008). Importantly, there is a clear need for clear structural
studies on eukaryotic enzymes to determine not only the catalytic
site, but also the structure of likely regulatory domains, such
as the N-terminus, which are not present in the prokaryotic
enzymes.
Progress in understanding the structure of eukaryotic DGKs
including DGK-θ has been hampered by our inability to purify
a sufficient amount of enzyme in a uniform, monodisperse
solution that would be amenable to classic methodologies such
as NMR and X-ray crystallography. So far, only the SAM (sterile
alpha motif) domain of DGKδ1 has been determined by x-ray
crystallography at a resolution of 2.9 angstrom (Harada et al.,
2008). This study indicated that oligomerization of the SAM
domain in a head to tail orientation leads to the cytosolic
sequestration, and inhibition, of this enzyme. In addition to this
structure, a solution structure of the C1 domain of DGKδ1, and
although a structure of DGKα has been deposited in a structure
database, it has not yet been published. We are clearly in need
of new and creative approaches to determine the structure of
DGK-θ and other DGK isoforms.
ENZYMOLOGY
DGK-θ belongs to a class of enzymes referred to as interfacial
enzymes. These enzymes are generally soluble and have at
least one insoluble substrate that is present in membranes or
lipid aggregates. As a result, the enzymology of these enzymes,
including DGK-θ, cannot be approached as is done for soluble
enzymes with soluble substrates. Binding to membranes is often
independent of catalysis and enzyme and substrate approach each
other via diffusion within a membrane or lipid aggregate. Further
complicating the analyses is the amount of time the enzyme
resides on the interface, i.e., the enzyme’s processivity, which may
vary with the composition or architecture of the interface. We
recently published a protocol (Tu-Sekine and Raben, submitted)
that outlines an approach to the enzymology of these enzymes.
Analyses of DGK-θ present in cytosolic lysates illuminated
two interesting aspects of its regulation (Tu-Sekine et al., 2006,
2007; Tu-Sekine and Raben, 2010). First, the enzyme is sensitive
to both the bulk as well as surface concentration of the DAG
substrate (Tu-Sekine et al., 2007). Second, the apparent Km
(Km(app)) of the enzyme in these lysates was dependent on
prior treatment of the cells. When DGK-θ was overexpressed in
fibroblasts, the Km(app) of the enzyme for diacylglycerol (DAG)
was increased in lysates obtained from mitogen-induced cells.
The Km(app) then decreased with increasing bulk concentration
of DAG. Additionally, the apparent Vmax (Vmax(app)) was
increased in response to increases in the product, PtdOH (Tu-
Sekine et al., 2007). It is noteworthy that the activation of DGK-
θ in response to PtdOH occurs at 6-fold lower surface and
bulk concentrations of DAG than observed when the activation
occurs in response to phosphatidyserine (PtdSer). Importantly,
the significant changes in the KM and Vmax values were observed
only when physiological levels of both PtdOH and PtdSer were
reached (Tu-Sekine et al., 2007).
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To fully understand the enzymology, studies must be
conducted on purified enzymes. One of the surprising discoveries
when isolated DGK-θ was analyzed was that the enzyme is not
fully active when purified. Full activity was observed when the
purified enzyme was assayed in the presence of proteins rich in
polybasic residues. In the presence of such polybasic cofactors,
which directly interact with the enzyme, the apparent K(m) of
the enzyme for DAG at the membrane surface (K(m)((surf)))
was decreased These cofactors also decreased the Km for ATP.
Furthermore, the cofactors synergistically increase the activity
10- to 30-fold in the presence of acidic phospholipids which were
known to enhance enzyme activity (below).
There has been considerable interest in gaining a complete
understanding of the enzymology and catalytic mechanism
of DGK-θ and related kinases. In 2002, an interesting
review appeared that highlighted the possibility that the
similarity in phosphate-donor-binding sites may lead to a
similar phosphorylation mechanism for four enzymes; DGKs,
sphingosine kinases, NAD kinases, and phosphofructo-6-
kinase (Labesse et al., 2002). Clearly, a confirmation of this
hypothesisfor DGKs requires a comprehensive understanding of
their structures. For example, it is possible that DGK-θ and other
DGKs, act as a dimer similar to that suggested for DGKB in
Staphylococcus aureus (Miller et al., 2008). Indeed, this may be
a common paradigm for lipid kinases as another lipid kinase,
sphingosine kinase 1, has also been suggested to function as a
dimer (see Adams et al., 2016). As with enzymes in general, a
complete understanding of DGK-θ’s enzymology and catalytic
mechanism will also provide critical information for the design
of specific DGK-θ inhibitors.
REGULATION
As noted above, DGK-θ is very sensitive to the bulk and surface
concentration of the DAG substrate. This provides a mechanism
for regulating the enzyme in response to increases in DAG that
accompany many signaling pathways. Additionally, as noted,
DGK-θ activity is increased in response to PtdSer as well as
PtdOH. Taken together, the data suggest that when DAG is
generated in a signaling pathway, the Km(app) decreases and as
the DAG concentration and PtdOH concentrations increase, the
enzyme becomes more efficient. This could help explain the very
transient nature of DAG increases in signaling pathways.
In addition to variations in membrane lipids, there are
strong data supporting a role for protein-protein interactions
that regulate DGK-θ activity. In 1999, Houssa et al. reported
that activated (GTP-bound) RhoA associated with DGK-θ and
inhibited its activity. Consistent with these data, Nurrish and
colleagues have provided some fascinating data showing the
homolog of DGK-θ in C. elegans, DGK-1, is regulated by
RhoA and to modulate acetylcholine release at neuromuscular
junctions (Nurrish et al., 1999; McMullan et al., 2006). As
indicated above, there is a Ras-associating (RA) domain within
the PH domain of DGK-θ and it has been tempting to speculate
that this region was responsible for RhoA binding. Los et al.,
however, showed that RhoA bound to the C-terminal portion
of the catalytic domain although they did not completely rule
out another interaction with the RA domain (Los et al., 2004).
While the precise RhoA binding regions have not been fully
identified, a potential important role for these interactions is
given support from the observations that other DGKs may show
similar associations. For example, Tolias et al. presented evidence
that a DGK associated with Rac1 (Tolias et al., 1998). This
enzyme, however, is unlikely to be DGK-θ as another study
showed DGK-θ does not associate with Rac1 or cdc42 (Houssa
et al., 1999).
The role of phosphorylation in regulating DGK-θ is unclear.
Using lysates of Cos-7 cells, PKC-ε has been shown to
phosphorylate DGK-θ in vitro and studies using A431 cells
suggested that this phosphorylation may promote membrane
association (van Baal et al., 2005). Akt has also been shown to
associate with and stimulate DGK-θ catalytic activity. Consistent
with this, PI-3 kinase regulates the translocation and activation
of DGK-θ in rat mesenteric arteries although, importantly, the
mechanism of this regulation is unclear and may not involve
DGK-θ phosphorylation (Walker et al., 2001; Clarke et al., 2007).
Additional studies are clearly required to define the precise role of
DGK-θ phosphorylation in membrane association and catalytic
activation.
As indicated above, full activation of DGK-θ requires an
acidic phospholipid and a polybasic cofactor. Additional analyses
showed that while the acidic phospholipids recruit polybasic
cofactors to the surface of artificial membranes, they do not
affect the membrane association of DGK-θ suggesting interfacial
association and catalytic activity are independently regulated.
The data provide support for a model (Figure 2) in which DGK-θ
exists as an auto-inhibited enzyme and that full interfacial activity
requires a triad of enzyme, acidic lipid, and basic protein (Tu-
Sekine et al., 2007). The enzyme is also likely to be modulated
by the presence of RhoA or another small GTPase under
physiological conditions. Importantly, the polybasic protein that
represents the physiological regulator of DGK-θ in various
tissues has/have not been identified and represents an important
challenge in the field.
PHYSIOLOGICAL ROLES
Regulation of Gene Expression
DGK-θ shows a broad tissue distribution with a regulated
expression profile (Ohanian and Ohanian, 2001; Topham, 2006;
Ueda et al., 2013). These studies has shown it is present in
various tissues that include brain, intestine, liver, kidney, and
small arteries and our understanding of its physiological roles
are beginning to emerge. One of the physiological roles identified
for DGK-θ was as a modulator of gene expression (Li et al.,
2007). Consistent with this, DGK-θ has been found to localize
in the nucleus in some cells (Bregoli et al., 2001, 2002; Tabellini
et al., 2003, 2004). In two immortalized neuronal cell lines (PC-12
and N2a) the enzyme has been found in speckle domains of the
nucleus within a subpopulation of cells (Tabellini et al., 2003).
As speckle domains are known to contain splicing factors, these
data suggest that DGK-θ may play a role in RNA processing.
In support of this notion, NGF (nerve growth factor) induces
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FIGURE 2 | Proposed model for DGK-θ membrane association and activation. In this model, DGK-θ exists in an auto-inhibited state which can bind to
membranes in the presence or absence of a protein activator containing a polybasic region. Following membrane binding, full activation is achieved when a triad
complex forms composed of enzyme, polybasic protein, and phospholipid activator.
an increase in the level and activity of DGK-θ in the nucleus
(Tabellini et al., 2003). Some of the most compelling evidence
supporting a role for DGK-θ in modulating gene expression has
been provided by Sewer and colleagues (Li et al., 2007; Cai and
Sewer, 2013; Cai et al., 2014). They show DGK-θ plays a role
in the activation of the nuclear receptor steroidogenic factor 1
(SF-1). Knock down of DGK-θ, but not DGK-ζ, or expression
of a kinase-dead mutant of DGK-θ abrogated agonist-induced
expression of SF-1-mediated genes (Li et al., 2007). This presents
another exciting area for future investigations to illuminate the
role of DGK-θ-mediated nuclear PtdOH production.
Regulation of Synaptic Cycling and
Neurotransmission
Nine of the ten known mammalian DGKs are expressed in
neurons (see Tu-Sekine and Raben, 2011; Ishisaka and Hara,
2014). This isoform has been shown to be expressed throughout
the brain with the strongest expression found in the hippocampus
and cerebellar cortex (Houssa et al., 1997; Tu-Sekine and Raben,
2011; Ueda et al., 2013; Ishisaka and Hara, 2014). Recently,
interest in the roles and regulation of DGKs in the mammalian
central nervous system (CNS) has grown (Tu-Sekine and Raben,
2011; Ishisaka andHara, 2014). However, as all ten DGK isoforms
are abundant in this tissue, determination of unique cellular
functions for each DGK isoform has been difficult. DGK-θ is
expressed early during brain during development (Ueda et al.,
2013) and subsequently maintained through adulthood where it
has been detected in the adult nervous system (Houssa et al.,
1997; Tu-Sekine and Raben, 2011; Ueda et al., 2013; Goldschmidt
et al., 2016). Initial studies implicating a role for DGK-θ in
synapse function came from elegant work on the C. elegans
homolog of DGK-θ, DGK-1 (Nurrish et al., 1999;McMullan et al.,
2006). Nurrish et al. showed that loss-of-function mutations in
DGK-1 potentiated acetylcholine at neuromuscular junctions.
This increase appears to be due to hyper-stimulation of the DAG-
binding vesicle-priming protein unc-13 (Nurrish et al., 1999;
Miller et al., 1999; and see Kanoh et al., 2002; Mérida et al.,
2008). Based on these data, we speculated DGK-θ might regulate
a similar function at mammalian central synapses (Goldschmidt
et al., 2016). We found DGK-θ localized to excitatory synapses
where its kinase activity promotes retrieval of synaptic vesicles
following neuronal activity. Acute depletion of DGK-θ using
shRNAs or significantly impaired the recycling kinetics of SVs.
The same effect was observed in neurons derived from mice in
which DGK-θ was genetically ablated although the mice were
overtly normal. Importantly, the SV defect could only be rescued
expression of enzymatically active DGK-θ, but not a kinase-dead
enzyme. The data presented not only establish a role for DGK-θ
kinase activity in SV cycling, but further analyses showed DGK-θ
is likely to be important for synaptic transmission when sustained
neuronal activity is required (Goldschmidt et al., 2016).
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Pathophysiological Roles
At the present time, there is very little data regarding the
pathophysiological role of DGK-θ. As noted earlier, this enzyme
has been shown to be regulated in mesenteric arteries. The
data suggests that this enzyme may play a role in regulating
blood pressure in response to noradrenalin but not angiotensin
II (Walker et al., 2001; Clarke et al., 2007). Clearly, this
could have important implications for treating hypertension
or pathophysiological conditions in which hypertension is a
complicating factor. Other data suggest that RhoA-mediated
inhibition of DGK-θ mediates ischemia/reperfusion injury in
liver by allowing for the elevation of DAG (Baldanzi et al.,
2010). Given the potential role for DGK-θ in modulating SF1
(above), it is tempting to speculate that this enzyme may play
a role in diseases associated with this transcription factor (El-
Khairi and Achermann, 2012). Our recent studies suggest that
DGK-θ may play a critical role during sustained or intense
neuronal stimulation (Goldschmidt et al., 2016) and therefore,
may play a key role in modulating seizures. Taken together,
while there are intriguing data regarding the physiologivcal and
pathophysiological roles of DGK-θ additional studies are clearly
needed.
FUTURE DIRECTIONS
While we have learned quite a bit about DGK-θ, there
is clearly much more to be discovered. Understanding the
structure of DGK-θ will provide essential insights into its
catalytic mechanism and regulation. Developing new strategies
to elucidate the structure of this enzyme, and identification
of physiologically relevant polybasic regulators will be key in
our understanding of this enzyme. Such data will be critical
in our efforts to develop specific inhibitors for this isozyme
which are at present not available. The importance of such
inhibitors will be highlighted as we learn more about the
various physiological roles of DGK-θ. For example, if DGK-θ
is indeed critical during intense neuronal stimulation, a specific
inhibitor may be useful in the treatment pathophysiological
conditions in which such stimulation plays an important
role (e.g., epilepsy). Conversely, the enzyme may play a role
under physiological conditions where rapid SV cycling is
essential such as ribbon synapses of some sensory neurons.
The future of research on DGK-θ promises to be exciting and
impactful.
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